Skip to main content

Table 2 Overview of clinically significant reportable CMR findings

From: Study protocol: MyoFit46—the cardiac sub-study of the MRC National Survey of Health and Development

Category

Pathology

Ventricular structure

Moderate-severe LV hypertrophy

Ventricular function

Moderate-severe LV impairment

Moderate-severe RV impairment

Atrial size

Moderate-severe atrial dilation

Valvular pathology

Structural valve abnormalities e.g. bicuspid aortic valve

Moderate-severe valvular stenosis

Moderate-severe valvular regurgitation

Pericardial effusion

Moderate-severe pericardial effusion

Cardiac tamponade

Shunts

Ventricular septal defect

Atrial septal defect

Cardiac masses

LV thrombus

Intracardiac mass

Valvular mass e.g. vegetation/fibroelastoma

Myocardial inflammation

Acute/chronic myocardial inflammation

Myocardial infarction

Acute/chronic myocardial infarction

Myocardial fibrosis

Clinically significant LGE

Perfusion defects

Clinically significant inducible perfusion defects

Extra cardiac findings

Other suspected, significant or life-threatening finding

  1. LGE, Late gadolinium enhancement; LV, left ventricle; RV, right ventricle